The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot, open study to assess efficacy and safety of ON-01910 (rigosertib) in patients with recessive dystrophic epidermolysis bullosa associated locally advanced/metastatic squamous cell carcinoma.
 
Lauren Banner
No Relationships to Disclose
 
Linda Hosler
No Relationships to Disclose
 
Matthew Parris
Employment - Onconova Therapeutics
Leadership - Onconova Therapeutics
Stock and Other Ownership Interests - Onconova Therapeutics
Patents, Royalties, Other Intellectual Property - Onconova Therapeutics
 
Mark Stephen Gelder
Employment - Onconova Therapeutics
Leadership - Onconova Therapeutics
Stock and Other Ownership Interests - Onconova Therapeutics
Research Funding - Onconova Therapeutics
Patents, Royalties, Other Intellectual Property - Onconova Therapeutics
Travel, Accommodations, Expenses - Onconova Therapeutics
 
Martin Laimer
Speakers' Bureau - Amryt Pharma
Research Funding - Amryt Pharma; Bristol-Myers Squibb; Holostem Terapie Avanzate; Onconova Therapeutics; Rheacell
 
Johann Bauer
Stock and Other Ownership Interests - Diaderm GmbH; KBHB Consult GmbH
Honoraria - Amryt Pharma; Janssen
Consulting or Advisory Role - Amryt Pharma; Janssen
Speakers' Bureau - Amryt Pharma; Janssen
Patents, Royalties, Other Intellectual Property - mproved pre-mRNA trans-splicing molecule (RTM) molecules and their uses. PCT/EP2009/00538; US 8,735,366 B2 Inventors: Bauer JW, Mitchell L;• Method for identifying compounds that control the translational activity of ribosomal proteins in differential mRN
 
Andrew South
Stock and Other Ownership Interests - Krystal Biotech
Honoraria - Amryt Pharma; Krystal Biotech
Research Funding - Eliksa Therapeutics; Eloxx Pharmaceuticals
Travel, Accommodations, Expenses - Amryt Pharma
 
Neda Nikbakht
Consulting or Advisory Role - Helsinn Therapeutics; Kyowa Kirin
Research Funding - Helsinn Therapeutics